Literature DB >> 33529985

Cognitive function, fatigue and Fazekas score in patients with acute neuroborreliosis.

Silje Andreassen1, Elisabeth Margrete Stokke Lindland2, Anne Marit Solheim3, Mona Kristiansen Beyer4, Unn Ljøstad3, Åse Mygland5, Åslaug Rudjord Lorentzen6, Harald Reiso7, Hanne Flinstad Harbo8, Gro Christine Christensen Løhaugen9, Randi Eikeland10.   

Abstract

Long-term cognitive problems and fatigue after adequately treated neuroborreliosis has caused uncertainty and debate among patients and health care workers for years. Despite several studies, the prevalence, cause and severity of such complaints are still not clarified. More knowledge about cognitive function, fatigue and MRI findings in the acute phase of neuroborreliosis could possibly contribute to clarification. In the current study, we therefore aimed to address this. Patients with well-characterized acute neuroborreliosis (n = 72) and a matched control group (n = 68) were screened with eight subtests from three different neuropsychological test batteries assessing attention, working memory and processing speed, and with Fatigue Severity Scale. Fazekas score was used to grade white matter hyperintensities on MRI. We found no differences in mean scores on the neuropsychological tests between the groups. The patient group reported significantly higher level of fatigue (Fatigue Severity Scale: 4.8 vs. 2.9, p < .001). There was no significant difference in Fazekas score between the groups. Neuroborreliosis does not seem to affect cognitive functions in the acute state of the disease, while fatigue is common.
Copyright © 2021 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Acute neuroborreliosis; Cognitive function; Fatigue; Fazekas

Year:  2021        PMID: 33529985     DOI: 10.1016/j.ttbdis.2021.101678

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  1 in total

1.  Cognitive function in patients with neuroborreliosis: A prospective cohort study from the acute phase to 12 months post treatment.

Authors:  Silje Andreassen; Anne Marit Solheim; Unn Ljøstad; Åse Mygland; Åslaug Rudjord Lorentzen; Harald Reiso; Mona Kristiansen Beyer; Hanne Flinstad Harbo; Gro Christine Christensen Løhaugen; Randi Eikeland
Journal:  Brain Behav       Date:  2022-05-20       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.